Published on
June 25, 2024
- 14:00 GMT
VUNO’S CORE TECHNOLOGY FOR EARLY DIAGNOSIS OF ALZHEIMER'S RECEIVED U.S. PATENT
VUNO Med®-DeepBrain® to Officially Launch in the U.S. in July, and is set to be Showcased at AAIC. MARLBOROUGH, MA, U.S., June 25, 2024 /EINPresswire.com/ -- VUNO—acclaimed as a pioneer in AI-based medical solutions—announced that a new U.S. patent has …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
